These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 1391529)

  • 1. Enhancement by perflusion emulsion (Oxygent) and carbogen breathing of the tumor growth delay of the FSaIIC fibrosarcoma after treatment with antitumor alkylating agents.
    Holden SA; Teicher BA; Ha C; Ara G; Herman TS
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):895-8. PubMed ID: 1391529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new concentrated perfluorochemical emulsion and carbogen breathing as an adjuvant to treatment with antitumor alkylating agents.
    Teicher BA; Holden SA; Ara G; Ha CS; Herman TS; Northey D
    J Cancer Res Clin Oncol; 1992; 118(7):509-14. PubMed ID: 1624542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Approaches to defining the mechanism of enhancement by Fluosol-DA 20% with carbogen of melphalan antitumor activity.
    Teicher BA; Holden SA; Jacobs JL
    Cancer Res; 1987 Jan; 47(2):513-8. PubMed ID: 3098413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of fractionated radiation therapy by an experimental concentrated perflubron emulsion (Oxygent) in the Lewis lung carcinoma.
    Teicher BA; Herman TS; Menon K
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):899-902. PubMed ID: 1391530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluosol-DA/carbogen with lonidamine or pentoxifylline as modulators of alkylating agents in the FSaIIC fibrosarcoma.
    Teicher BA; Herman TS; Tanaka J; Dezube B; Pardee A; Frei E
    Cancer Chemother Pharmacol; 1991; 28(1):45-50. PubMed ID: 1904012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of alkylating agents by etanidazole and Fluosol-DA/carbogen in the FSaIIC fibrosarcoma and EMT6 mammary carcinoma.
    Teicher BA; Herman TS; Tanaka J; Eder JP; Holden SA; Bubley G; Coleman CN; Frei E
    Cancer Res; 1991 Feb; 51(4):1086-91. PubMed ID: 1825474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Restoration of tumor oxygenation after cytotoxic therapy by a perflubron emulsion/carbogen breathing.
    Teicher BA; Holden SA; Ara G; Dupuis NP; Goff D
    Cancer J Sci Am; 1995; 1(1):43-8. PubMed ID: 9166453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of perfluorochemical emulsions in cancer therapy.
    Teicher BA
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):875-82. PubMed ID: 1391527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic effect of infused Fluosol-DA/carbogen with ephedrine, flunarizine, or nitroprusside.
    Teicher BA; Holden SA; Northey D; Dewhirst MW; Herman TS
    Int J Radiat Oncol Biol Phys; 1993 Apr; 26(1):103-9. PubMed ID: 8482616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of fluosol-DA/carbogen on etoposide/alkylating agent antitumor activity.
    Teicher BA; Bernal SD; Holden SA; Cathcart KN
    Cancer Chemother Pharmacol; 1988; 21(4):281-5. PubMed ID: 3131032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical evaluation of Oxygent as an adjunct to radiotherapy.
    Rockwell S; Kelley M; Irvin CG; Hughes CS; Yabuki H; Porter E; Fischer JJ
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):883-93. PubMed ID: 1391528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of various oxygenation conditions on the enhancement by Fluosol-DA of melphalan antitumor activity.
    Teicher BA; Crawford JM; Holden SA; Cathcart KN
    Cancer Res; 1987 Oct; 47(19):5036-41. PubMed ID: 3113727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of scheduling, dose, and volume of administration of a perfluorochemical emulsion on tumor response to radiation therapy.
    Teicher BA; Herman TS; Jones SM
    Int J Radiat Oncol Biol Phys; 1990 Oct; 19(4):945-51. PubMed ID: 2211263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of a bovine hemoglobin preparation on the response of the FSaIIC fibrosarcoma to chemotherapeutic alkylating agents.
    Teicher BA; Herman TS; Hopkins RE; Menon K
    J Cancer Res Clin Oncol; 1992; 118(2):123-8. PubMed ID: 1735732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of fluosol-DA and oxygenation status on the activity of cyclophosphamide in vivo.
    Teicher BA; Herman TS; Holden SA; Cathcart KN
    Cancer Chemother Pharmacol; 1988; 21(4):286-91. PubMed ID: 3131033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Addition of misonidazole, etanidazole, or hyperthermia to treatment with fluosol-DA/carbogen/radiation.
    Teicher BA; Herman TS; Holden SA; Jones SM
    J Natl Cancer Inst; 1989 Jun; 81(12):929-34. PubMed ID: 2525198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survey of the effect of adding Fluosol-DA 20%/O2 to treatment with various chemotherapeutic agents.
    Teicher BA; Holden SA
    Cancer Treat Rep; 1987 Feb; 71(2):173-7. PubMed ID: 3100035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of various oxygenation conditions and fluosol-DA on cytotoxicity and antitumor activity of bleomycin in mice.
    Teicher BA; Holden SA; Cathcart KN; Herman TS
    J Natl Cancer Inst; 1988 Jun; 80(8):599-603. PubMed ID: 2453675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Fluosol-DA/O2 on tumor-cell and bone-marrow cytotoxicity of nitrosoureas in mice bearing FSA-II fibrosarcoma.
    Teicher BA; Holden SA; Rose CM
    Int J Cancer; 1986 Aug; 38(2):285-8. PubMed ID: 3089945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimization of perfluorochemical levels with radiation therapy in mice.
    Teicher BA; Herman TS; Jones SM
    Cancer Res; 1989 May; 49(10):2693-7. PubMed ID: 2713854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.